Nghia Hoang, DO
Clinical Cardiac Electrophysiology · Panama City, FLNPI 1740235498
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 73.3% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $16,214, 4.5 times the $3,624 reported in 2019.
Across 302 payments — averaging $134.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$30K
- Boston Scientific$5K
- Medical Device Business Services, Inc.$2K
- Biosense Webster, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$371
- E.r. Squibb & Sons, L.L.C.$298
- plus $2K from 23 others
Across 97 payments — averaging $1373.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$133K
What the payments were for
- Speaking & faculty fees$16,80041%
- Travel & lodging$13,82834%
- Food & beverage$10,12825%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 102 | $29,870 |
| Boston Scientific | 50 | $5,265 |
| Medical Device Business Services, Inc. | 10 | $1,674 |
| Biosense Webster, Inc. | 23 | $1,223 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $371 |
| E.r. Squibb & Sons, L.L.C. | 17 | $298 |
| Abbott | 4 | $245 |
| Abiomed | 2 | $239 |
| Pfizer | 12 | $237 |
| Novartis | 14 | $222 |
| Merck | 11 | $213 |
| Amgen | 10 | $182 |
| Sanofi-aventis U.S. LLC | 5 | $97 |
| Amarin Pharma, Inc. | 5 | $94 |
| Lilly USA, LLC | 1 | $90 |
| Johnson & Johnson | 4 | $58 |
| Kestra Medical Technology Services, Inc. | 2 | $51 |
| Chiesi USA, Inc. | 1 | $41 |
| Philips North America LLC | 2 | $38 |
| Elutia, Inc. | 3 | $35 |
| AstraZeneca | 2 | $34 |
| Bayer | 2 | $32 |
| Cvrx, Inc. | 2 | $29 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Cagent Vascular Inc | 1 | $17 |
| Altathera Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PulseSelect$2,611
- EVERA MRI XT DR SURESCAN$1,714
- Carto 3 System$1,407
- GENERAL - THERAPIES$1,105
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
- Watchman$676
- Micra$400
- Carto 3$345
- AFFERA MAPPING SYSTEM$297
- AZURE XT DR MRI SURESCAN$292
- Impella$239
- NA$128
- CartoSound$121
- QDOT MICRO Catheter$114
- Rhythmia Mapping System$112
- LINQ II$112
- Reveal LINQ$109
- Farapulse$102
- WATCHMAN Access System$101
- CROME DR MRI SURESCAN$101
How this compares
$40,756 in reported general payments places this provider in the 65th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 691 | $585,442 |
| EntrestoSacubitril/Valsartan | 297 | $260,087 |
| XareltoRivaroxaban | 174 | $140,021 |
| CamzyosMavacamten | 11 | $88,313 |
| FarxigaDapagliflozin Propanediol | 52 | $38,184 |
| JardianceEmpagliflozin | 20 | $17,561 |
| Metoprolol Succinate | 510 | $7,273 |
| BrilintaTicagrelor | 15 | $6,625 |
| Carvedilol | 518 | $4,168 |
| Flecainide Acetate | 128 | $3,449 |
| Losartan Potassium | 292 | $2,757 |
| ClopidogrelClopidogrel Bisulfate | 113 | $1,821 |
| Digoxin | 97 | $1,699 |
| Amiodarone Hcl | 137 | $1,692 |
| Atorvastatin Calcium | 139 | $1,328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $237 | $585,442691 claims |
| NovartisEntresto | $222 | $260,087297 claims |
| Johnson & JohnsonXarelto | $58 | $140,021174 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $298 | $88,31311 claims |
| AstraZenecaFarxiga, Brilinta | $34 | $44,80967 claims |
| Boehringer IngelheimJardiance | $20 | $17,56120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Panama City
- Saeed KhajaPanama City$55K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.